Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
Expected marginal mean QoL scores for two age cohorts over 2016–2024 in Gauteng, South Africa.
Published 2025Subjects: -
4
-
5
-
6
-
7
Socio-demographic factor for two cohorts aged 18-24 and 32-38 in 2016 in Gauteng.
Published 2025Subjects: -
8
-
9
-
10
Sample Size for QoL tracking study for young people aged 18 to 24 in Gauteng, 2016 - 2024.
Published 2025Subjects: -
11
Quality of Life changes between 2016 and 2024 for two age cohorts staying in Gauteng.
Published 2025Subjects: -
12
-
13
-
14
Identified problem nutrients and dietary inadequacy in 24-59mo children, by district.
Published 2024Subjects: -
15
Baseline characteristics of study participants.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
-
16
The numerical data used in this study.
Published 2025“…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
-
17
-
18
-
19
The 2-best diets, worst-case scenario and optimized FBRs for 36-59mo children.
Published 2024Subjects: -
20